Rachel Hartford

Lead Consumer Safety Officer, Office of New Drugs, CDER
Rachel Hartford is the team leader of the Office of New Drugs’ Enhanced Communication Team (ECT).
Prior and since 2007, Rachel Hartford was a regulatory health project manager for insulin products in the Division of Metabolism and Endocrinology Products.
Before coming to FDA, Rachel Hartford was a chemist for the United States Army Center for Health Promotion and Preventative Medicine Europe.